8 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... randomized controlled trial ... #Cancer #Algorithm ... Anticoagulation #Management ... #Hematology #Oncology
Approach to the Hypercoagulable State
Arterial thromboembolism
→ Cardiac rhythm monitoring, Echocardiogram, Vascular imaging
→ Test for APS, particularly
thromboembolism (VTE ... Age-appropriate cancer ... Age-appropriate cancer ... #diagnosis #algorithm ... #hematology #VTE
Approach to Thrombocytosis - Elevated Platelet Count - Differential Diagnosis Algorithm

Peripheral Smear concerning for malignancy?
Count - Differential ... Diagnosis Algorithm ... Malignancy: Metastatic cancer ... Glucocorticoids, IL-1B, ATRA ... Differential #Diagnosis #Algorithm
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... for VTE in Malignancy ... #Cancer #Algorithm ... Anticoagulation #Management ... #Hematology #Oncology
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Thromboembolism Treatment Algorithm ... at 3 Months • Cancer ... therapy - Second VTE ... Thromboembolism #Treatment #Algorithm ... #management #hematology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
to perform own ADLs ... event, follow ACC algorithm ... • <3mo since VTE ... CARP, DECREASE V trials ... medical and surgical management
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
abnormality is platelet ... count > ~450,000 ... • Treatment algorithms ... #diagnosis #management ... #hematology
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
current treatment algorithm ... From Blood Cancer ... neutrophils or platelets ... importance of clinical trial ... #algorithm #hematology